(18)F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma

OBJECTIVE: MET is a member of the receptor tyrosine kinases. Several MET-targeting inhibitors and antagonistic antibodies have shown promising data in clinical trials of lung adenocarcinoma. Finding noninvasive diagnostic tools to estimate the status of MET is helpful in clinical practice. (18)F-flu...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Shuxian, Zhou, Xiang, Liu, Jianjun, Huang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709992/
https://www.ncbi.nlm.nih.gov/pubmed/29225472
http://dx.doi.org/10.2147/OTT.S150334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709992/
https://www.ncbi.nlm.nih.gov/pubmed/29225472
http://dx.doi.org/10.2147/OTT.S150334

Ejemplares similares